سعر فروبن اس ار 200 مجم 10 كبسولات 2026

Flurbiprofen 200 mg sustained-release capsule, 10 capsules per pack, manufactured by Kahira Pharmaceuticals for Abbott Laboratories (Egypt); propionic acid-derivative NSAID.

• Most common (>3%): abdominal pain, dyspepsia, nausea, diarrhoea, constipation, headache, oedema and signs suggesting urinary tract infection.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity (e.g. anaphylaxis, serious skin reactions) to flurbiprofen or any component.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• History of asthma, urticaria or other allergic-type reactions after aspirin or other NSAIDs.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• In the setting of coronary artery bypass graft (CABG) surgery.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Boxed warning: NSAIDs increase the risk of serious cardiovascular thrombotic events (myocardial infarction, stroke), which can be fatal and may occur early in treatment.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Boxed warning: NSAIDs increase the risk of serious gastrointestinal bleeding, ulceration and perforation, which can be fatal; elderly patients and those with prior ulcer/GI bleeding are at greater risk.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Other warnings include hepatotoxicity, hypertension, heart failure and oedema, renal toxicity and hyperkalaemia, anaphylactic reactions, serious skin reactions and haematological toxicity.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Anticoagulants (e.g. warfarin), antiplatelet agents (e.g. aspirin), SSRIs/SNRIsIncreased risk of serious bleeding; monitor for bleeding.DailyMed (U.S. National Library of Medicine)

• NSAIDs can cause premature closure of the fetal ductus arteriosus and fetal renal dysfunction leading to oligohydramnios; limit dose and duration between about 20 and 30 weeks and avoid from about 30 weeks of gestation.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Flurbiprofen is poorly excreted into human milk (predicted infant dose about 0.1 mg/day at a maternal dose of 200 mg/day); weigh benefits against risks.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Flurbiprofen: Inhibits cyclo-oxygenase (COX-1 and COX-2), reducing prostaglandin synthesis.